Intended for adults with a rare genetic eye condition, the implant replaces the function of degenerated cells in the retina. Read related article.


Sources: FDA, Second Sight Medical Products, Inc. | Alberto Cuadra and Laris Karklis/The Washington Post February 14, 2013
Comments
Show Comments